At a glance
ClinicalIndex Comparison RecordN/ACompleted· 21 enrolled
Drug / intervention
Dexamethasonedrug
Likely dose
Dexamethasone 2mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin Effect
In Brief
A clinical study evaluating Dexamethasone for Insulin Resistance and Glucose Intolerance. Completed, enrolled 21 participants across 1 site.
Detailed Summary
The purpose of this study is to examine whether there is a causal relationship between insulin resistance and/or glucose intolerance in the development of a defect incretin effect.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInsulin Resistance, Glucose Intolerance
CountriesDenmark
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2008
First PostedNov 2008
Primary CompletionAug 2009
Study CompletionSep 2009
TodayJul 2026
First PostedNov 4, 2008
Enrollment StartNov 1, 2008
Primary CompletionAug 1, 2009
Study CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 17.7 years ago
Interventions
Dexamethasonedrug
2mg morning and night for 5 days.